Dareway(SH:688579)2024-04-12 16:00Financial Performance - The company's operating revenue for Q3 2022 was ¥157,226,981.75, representing a 32.18% increase compared to the same period last year[5] - The net profit attributable to shareholders for Q3 2022 was ¥37,418,188.12, a significant increase of 153.77% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses reached ¥32,405,714.50, reflecting a 162.96% increase compared to the previous year[5] - Basic earnings per share for Q3 2022 were ¥0.0935, up 153.39% from the same period last year[6] - Total operating revenue for the first three quarters of 2022 was RMB 253,010,991.20, a decrease of 1.1% compared to RMB 257,930,226.60 in the same period of 2021[22] - Net profit for the first three quarters of 2022 was RMB 24,558,588.36, an increase of 5% from RMB 23,388,392.39 in the previous year[23] - Basic and diluted earnings per share increased to RMB 0.0614 from RMB 0.0585, representing a growth of 4.9%[24] - The net profit for the first three quarters of 2022 was ¥25,895,689.76, compared to ¥25,215,330.59 in the same period of 2021, indicating an increase of about 2.7%[33] Research and Development - The total R&D investment for the period was ¥31,253,675.22, accounting for 19.88% of operating revenue, a decrease of 3.77 percentage points year-on-year[6] - The company reported a significant increase in R&D expenses to RMB 76,129,053.41, up from RMB 72,232,747.23, indicating a focus on innovation[22] - Research and development expenses for the first three quarters of 2022 were ¥72,967,795.20, up from ¥69,055,787.54 in the same period of 2021, representing an increase of about 4.2%[31] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,579,430,586.40, down 8.24% from the end of the previous year[6] - As of September 30, 2022, the total assets of the company amounted to RMB 1,579,430,586.40, a decrease from RMB 1,721,172,342.90 at the end of 2021, representing a decline of approximately 8.2%[18] - The company's total liabilities decreased to RMB 317,330,259.06 from RMB 448,035,470.59, indicating a reduction of about 29.2%[19] - The company's total liabilities decreased from ¥446,026,999.58 at the end of 2021 to ¥314,706,039.90 as of September 30, 2022, a reduction of approximately 29.4%[30] - The total current assets were reported at RMB 685,600,147.75, down from RMB 845,622,797.48, reflecting a decrease of approximately 19%[17] - The company's equity attributable to shareholders decreased to RMB 1,262,100,327.34 from RMB 1,273,136,872.31, a decline of approximately 0.9%[19] - The total equity of the company as of September 30, 2022, was ¥1,268,714,970.32, slightly down from ¥1,278,414,413.89 at the end of 2021, reflecting a decrease of approximately 0.9%[31] Cash Flow - The cash flow from operating activities for the year-to-date was negative ¥115,855,561.24, primarily due to delayed sales collections caused by the pandemic[10] - Cash flow from operating activities showed a net outflow of RMB -115,855,561.24, compared to a smaller outflow of RMB -45,332,266.42 in the same period last year[27] - Cash inflow from investment activities was RMB 553,089,098.64, while cash outflow was RMB 76,824,364.01, resulting in a net cash flow of RMB -76,824,364.01[27] - Cash flow from financing activities resulted in a net outflow of RMB -40,126,925.00, slightly higher than the outflow of RMB -40,051,001.00 in the previous year[27] - The cash flow from operating activities for the first three quarters of 2022 showed a positive trend, contributing to the overall financial stability of the company[35] - Operating cash flow for the first three quarters of 2022 was negative at -112,381,435.69, compared to -45,963,948.21 in the same period of 2021, indicating a decline in cash generation[36] - Total cash inflow from operating activities decreased to 273,749,862.26 in 2022 from 356,980,799.94 in 2021, a drop of approximately 23.3%[36] - Cash outflow from operating activities was 386,131,297.95 in 2022, slightly down from 402,944,748.15 in 2021, resulting in a net cash flow from operating activities of -112,381,435.69[36] - Investment activities generated a net cash flow of -81,817,669.01 in 2022, a significant decline from 382,678,863.50 in 2021[36] - The net increase in cash and cash equivalents for Q3 2022 was -234,200,104.70, contrasting with a positive increase of 296,663,914.29 in Q3 2021[37] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 7,703[12] - The largest shareholder, Shandong Shanda Capital Operation Co., Ltd., held 29.58% of the shares, totaling 118,342,400 shares[12] - The company reported a total of 68,342,560 shares held by Guoshou Chengda (Shanghai) Health Industry Equity Investment Center, making it the largest shareholder[13] Strategic Outlook - The company has not disclosed any significant new product developments or market expansion strategies during this reporting period[15] - The company has not disclosed any new product developments or market expansion strategies during the reporting period[36] - Future outlook remains cautious due to the significant decline in cash flow and overall financial performance[36]